ABVC BioPharma, Inc.
ABVC
$1.00
-$0.06-5.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.11M | -8.63M | -7.91M | -5.08M | -4.23M |
| Total Depreciation and Amortization | 491.70K | 483.00K | 504.70K | 168.40K | 178.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.07M | 5.52M | 5.03M | 3.49M | 2.60M |
| Change in Net Operating Assets | -146.90K | -712.40K | -615.30K | -851.30K | -629.50K |
| Cash from Operations | -2.69M | -3.34M | -2.99M | -2.27M | -2.08M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -597.50K | -1.16M | -1.21M | -1.48M | -164.20K |
| Cash from Investing | -597.50K | -1.16M | -1.21M | -1.48M | -164.20K |
| Total Debt Issued | 1.03M | 889.00K | 889.00K | 3.40K | -820.10K |
| Total Debt Repaid | -1.14M | -1.18M | -547.80K | -616.10K | -459.50K |
| Issuance of Common Stock | 2.27M | 4.31M | 4.30M | 3.84M | 3.30M |
| Repurchase of Common Stock | -- | -- | -- | -7.30K | -7.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -148.30K | 0.00 | 599.60K | 599.60K |
| Cash from Financing | 2.17M | 3.87M | 4.64M | 3.82M | 2.61M |
| Foreign Exchange rate Adjustments | 78.00K | 16.00K | 20.20K | 11.50K | -36.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.04M | -619.20K | 463.30K | 84.10K | 333.60K |